SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Valeant Reportedly Makes Bid for Zoetis in “Mega Deal”
June 26, 2015
 · 
3 min read
Business
Valeant Taps M&A Expert as New CFO As Dealmaking Roars
June 11, 2015
 · 
5 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Chief Calls Recent Biotech M&A “Bit of a Bubble”
May 22, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant in Talks to Pay $700 to $800 Million for Egyptian Drugmaker Amoun to Expand GI Line
May 20, 2015
 · 
4 min read
Billionaire Doubles Down On Valeant
May 19, 2015
 · 
1 min read
Business
Valeant Rewards Top Execs $123 Million for Surpassing 2014 Goals
April 21, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Valeant Exec’s $50.6 Million Paycheck Makes Him the Second Highest Paid Non-CEO Employee
April 13, 2015
 · 
8 min read
Job Trends
Valeant Sacks 258 Salix Employees; Confirms “Limited Presence” in North Carolina
April 3, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Sweetens Salix Deal to $173 Per Share After Teaming Up With Ackman and Endo International Withdraws
March 16, 2015
 · 
8 min read
Load More
IN THE PRESS
Valeant Comments On Management Change
March 3, 2016
 · 
2 min read
Business
Valeant Loses a Top Exec
March 3, 2016
 · 
1 min read
Business
EyeGate Pharma Receives Additional Milestone Payment From Valeant For EGP-437
March 2, 2016
 · 
2 min read
Activist Investor Bill Ackman Loses $321 Million in One Day as Valeant Plunges
March 2, 2016
 · 
1 min read
Drug Development
Female Libido Drug that Valeant Bought for $1 Billion Gets Mixed Reviews
March 1, 2016
 · 
1 min read
Business
Valeant Canada Selects IMS Health’s Fully Integrated Customer Engagement Solution For Commercial Effectiveness
February 2, 2016
 · 
4 min read
Valeant Has Found Another Enemy in Democratic Presidential Candidate Hillary Clinton
January 29, 2016
 · 
1 min read
Drug Development
Valeant Announces FDA Acceptance Of BLA Submission For Brodalumab In Moderate-To-Severe Plaque Psoriasis
January 25, 2016
 · 
3 min read
Business
Valeant CEO Pearson’s on the “On the Road to Recovery” But Timing of Return Uncertain
January 25, 2016
 · 
3 min read
Valeant To Present At The 34th Annual J.P. Morgan Healthcare Conference
January 5, 2016
 · 
1 min read
Load More